CRISPR is a gene editing technique that promises to revolutionize genetic engineering, but already is raising ethical, business, and legal issues. This is the first in a monthly series of articles on CRISPR. ...more
The Chinese government has been in the process of modernizing its telemedicine law and policy and associated infrastructure for nearly 2 years now, to support broad, domestic application of telemedicine. We outline one of the...more
7/11/2016
/ Big Data ,
China ,
Data-Sharing ,
Electronic Medical Records ,
Foreign Investment ,
Health Care Providers ,
Health Information Technologies ,
Infrastructure ,
Investors ,
New Guidance ,
Telemedicine
Telemedicine continues to attract international attention, with China on track to become one of the largest telemedicine markets in the world.
Just a year after the National Health and Family Planning Commission of the...more
As U.S. hospitals and health care providers continue to explore China’s market for international health care business opportunities, including telemedicine, they often consider providing services or products to consumers...more
9/28/2015
/ Advertising ,
China ,
Contract Drafting ,
Contract Negotiations ,
Endorsements ,
Health Care Providers ,
Healthcare ,
Hospitals ,
Proposed Regulation ,
Sanctions ,
Telemedicine
Manufacturers with operations, employees, and/or customers in China must be aware of a long list of China-specific data-flow and content restrictions. Data-flow restrictions in particular affect manufacturers employing or...more
5/31/2015
/ Banks ,
China ,
Criminal Prosecution ,
Criminal Sanctions ,
Cross-Border ,
Data Privacy ,
Healthcare ,
Information Security ,
Manufacturers ,
National Security ,
Personal Data ,
Popular ,
Technology
U.S. health care providers, device manufacturers, lab managers, health information technology and telemedicine/telehealth project investors, and other industry members involved in projects in China, need to be aware of a long...more
This post is the third in Foley’s blog series, “Realizing the Potential of Telemedicine in China,” meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market. We continue to work with...more
The Chinese market presents a tremendous opportunity for U.S. hospitals and providers, as long as the intricacies of data privacy and security issues are thoroughly understood. This includes Chinese regulations regarding...more
This post is the second in Foley’s blogs on China telemedicine and the first in the blog series, “Realizing the Potential of Telemedicine in China,” meant to address top issues facing U.S. companies looking to enter the...more
China announced its boldest plan in 30 years to overhaul a multitude of economic and social policies, with the release of “The Decision on Major Issues Concerning Comprehensively Deepening Reforms” on November 15,...more